News and Events
Contact
301-496-5449
Email nhlbi_news@nhlbi.nih.gov or call 301-496-5449 and ask for the press officer on duty.
|
Media Availability
WHAT: A scientist from the National Institutes of Health will present promising, early results from a human clinical trial testing a novel gene replacement therapy in people with severe sickle cell disease. Preliminary findings suggest that the approach has an acceptable level of safety and might help patients consistently produce normal red blood...
|
Statement
On November 21, World COPD Day 2018, the National Institutes of Health unites with millions of people to renew our long-standing commitment to reducing the burden of chronic obstructive pulmonary disease ( COPD ), a serious and debilitating lung disease. A leading cause of death, COPD impacts an estimated 251 million people worldwide . While many h...
|
Research Features
Feeling sleepy during the day? You’re not alone. Insufficient sleep is a common and fast-growing problem, with almost a third of U.S. adults reporting they get less than the recommended amount of shuteye. But while some people experience occasional restless nights that still allow them to be alert and productive during the day, many others experien...
|
Statement
The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, is pausing the CONCERT-HF trial , which involves patients with chronic heart failure. Recent calls for the retraction of journal articles in related fields of cell therapy research have raised concerns about the scientific foundations of this trial. Wh...
Featured Past Events
December 1
to
November 4,
2018
San Diego Convention Center, San Diego, CA
November 10
-
12, 2018
McCormick Place, Chicago, IL
October 16
-
17, 2018
Natcher Conference Center, Ruth L. Kirschstein Auditorium
45 Center Dr.
National Institute of Health, Bethesda, MD 20894
45 Center Dr.
National Institute of Health, Bethesda, MD 20894